Cross-platform comparison of independent datasets identifies an immune signature associated with improved survival in metastatic melanoma.
about
Mycobacterium bovis Bacillus Calmette-Guérin Alters Melanoma Microenvironment Favoring Antitumor T Cell Responses and Improving M2 Macrophage Function.Presence of immune cells, low tumor proliferation and wild type BRAF mutation status is associated with a favourable clinical outcome in stage III cutaneous melanomaMelanoma: Genetic Abnormalities, Tumor Progression, Clonal Evolution and Tumor Initiating Cells.
P2860
Cross-platform comparison of independent datasets identifies an immune signature associated with improved survival in metastatic melanoma.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 13 February 2016
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Cross-platform comparison of i ...... rvival in metastatic melanoma.
@en
Cross-platform comparison of i ...... rvival in metastatic melanoma.
@nl
type
label
Cross-platform comparison of i ...... rvival in metastatic melanoma.
@en
Cross-platform comparison of i ...... rvival in metastatic melanoma.
@nl
prefLabel
Cross-platform comparison of i ...... rvival in metastatic melanoma.
@en
Cross-platform comparison of i ...... rvival in metastatic melanoma.
@nl
P2093
P2860
P356
P1433
P1476
Cross-platform comparison of i ...... rvival in metastatic melanoma.
@en
P2093
Delphine J Lee
Jaime M Shamonki
John R Jalas
Marian S Navarrete
Peter A Sieling
Seema B Plaisier
P2860
P304
14415-14428
P356
10.18632/ONCOTARGET.7361
P407
P577
2016-02-13T00:00:00Z